Trial Profile

Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 18 Feb 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Brimonidine (Primary) ; Ivermectin (Primary)
Indications Rosacea
Focus Therapeutic Use
Acronyms MOSAIC
Sponsors Galderma; Galderma Research & Development

Most Recent Events

11 Sep 2017 Results from this trial have been published in the Journal of Drugs in Dermatology, according to a Galderma media release.
13 Jan 2017 Status changed from active, no longer recruiting to completed.
17 Jun 2016 Planned End Date changed from 1 Jun 2016 to 1 Sep 2016.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com